Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid

BACKGROUND: Tenofovir alafenamide fumarate (TAF) co-formulated with elvitegravir (EVG; E), cobicistat (C), and emtricitabine (F), a recommended antiretroviral regimen, was evaluated for distribution and antiviral activity in cerebrospinal fluid (CSF) as well as neurocognitive (NC) performance change...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Infect Dis
Main Authors: Ma, Qing, Ocque, Andrew J, Morse, Gene D, Sanders, Chelsea, Burgi, Alina, Little, Susan J, Letendre, Scott L
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Articles and Commentaries
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7428394/
https://ncbi.nlm.nih.gov/pubmed/31560741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz926
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki